Last reviewed · How we verify

Wangbi granules — Competitive Intelligence Brief

Wangbi granules (Wangbi granules) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Urology/Infectious Disease.

marketed Urology/Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Wangbi granules (Wangbi granules) — China-Japan Friendship Hospital. Wangbi granules is a traditional Chinese medicine formulation that works to clear heat, resolve toxicity, and promote urination to treat urinary tract infections and related conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Wangbi granules TARGET Wangbi granules China-Japan Friendship Hospital marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Wangbi granules — Competitive Intelligence Brief. https://druglandscape.com/ci/wangbi-granules. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: